Analyst Ratings for Health Catalyst Inc. (HCAT)
HCAT Rating Summary
HCAT Price Target Summary
- Highest: $5.00 (Canaccord)
- Lowest: $2.75 (Citi)
- Average: $4.06
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$4.06 (+108.3%)
* Over Last 12-Mos
Rating Score: 5.8 / 10
Percentile Rank: 62%
Avg. $ Target:
$4.06 (+108.3%)
* Over Last 12-Mos
Rating Score: 5.8 / 10
Percentile Rank: 62%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/27/2025 | Piper Sandler | Jessica Tassan | Downgrade | Neutral (Overweight) |
4.00 (8.00) |
3.50 (1.95) |
-44.29% | Details |
| 8/11/2025 | Citi » Updated 1/9/2026 |
Daniel Grosslight | Downgrade | Neutral (Buy) |
2.75 (3.25) |
3.69 (1.95) |
-47.15% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
